Skip to main content
Natco Pharma Ltd. logo

Natco Pharma Ltd. — Investor Relations & Filings

Ticker · NATCOPHARM ISIN · INE987B01026 LEI · 33580086GIBRWXSNGG39 BSE.NS Manufacturing
Filings indexed 1,708 across all filing types
Latest filing 2019-12-21 Regulatory Filings
Country IN India
Listing BSE.NS NATCOPHARM

About Natco Pharma Ltd.

https://www.natcopharma.co.in/

Natco Pharma Ltd. is a vertically integrated organization focused on the development, manufacturing, and marketing of complex generics and active pharmaceutical ingredients (APIs). The company specializes in niche therapeutic areas, maintaining a leadership position in oncology and a significant presence in specialty segments such as hepatology, cardiology, and diabetology. Natco is recognized for its expertise in high-barrier-to-entry products, including complex oral solids and injectables. Its business model emphasizes research and development to deliver affordable versions of life-saving medicines globally. With a robust portfolio of finished dosage formulations and a strong supply chain for APIs, the company serves diverse international markets, including North America, Europe, and emerging economies, through strategic partnerships and direct distribution channels.

Recent filings

Filing Released Lang Actions
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for VCN Family Pvt Trust & Sau Family Trust
Regulatory Filings
2019-12-21 English
Related Party Transactions
Regulatory Filings
2019-12-06 English
Related Party Transactions for the half year ended September 30,2019
Regulatory Filings
2019-12-06 English
Acquisition
Regulatory Filings Classification · 95% confidence The document text contains no substantive content, only placeholders for omitted images and no textual information. The true document length is only 106 characters, which is extremely short and contains no report or announcement details. Given the lack of any financial data, regulatory references, or report titles, this document cannot be classified as a financial report or announcement. It fits best as a Regulatory Filing (RNS) as a fallback category for miscellaneous filings with no clear classification.
2019-12-03 English
Intimation of completion of Investment
Regulatory Filings
2019-12-03 English
Investor Presentation
Regulatory Filings
2019-11-15 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.